Postprandial hyperglycemia
Conditions
Interventions
placebo food
active food
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1, Fasting blood glucose > 94, and <126 mg/dL 2, HbA1c (NGSP) > 5.1, and <6.5 3, Aged between 30 and 59 4, BMI >22.9 and <30 kg/m2 5, Person who can accept to be accessed their medical records and agree with the study protocol followed by a prior explanation 6, Person who provides informed consent by a document 7, Depends on the screening condition of above 1 to 3 criteria, person who does not meet the criteria can be screened in case that the physican in charge, the client and the CRO reach to agreement of it.
Exclusion criteria
Exclusion criteria: 1, Person who is difficult to participate the study due to dysfunctions of liver, kidney, heart, respiration, endocrine secretion, metabolism, nervous system, consciousness or diabetes, or the other dysfunctions 2, Person who was given surgery for a disease or an injury 2 months prior to the study 3, Person who was given gastrectomy and/or bypass of part of the intestine 4, Person who takes medication for glucose or fat metabolism, or hypertension 5, Person who habitually consumes the foods for specific health use (FOSHU) and/or dietary supplements (capsules) (except for person who can stop to consume them right after informed consent) 6, Person who is or had been given treatment for allergies to test food ingredients 7, Person who has been ill due to blood collecting 8, Person who donated 200mL or more of blood within a month prior to the study 9, Person who skip breakfast habitually 10, Heavy smoker or person who cannot stop
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postprandial blood glucose | — |
Secondary
| Measure | Time frame |
|---|---|
| Insulin, TG, GIP, GLP-1, ghrelin, appetite (satiety) | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co. Ltd Sales department for tissue engineering and clinical research
Outcome results
None listed